Andy Levinson

Andy Levinson has over 30 years of experience handling corporate and securities matters, including mergers, acquisitions and restructurings, as well as public and private debt and equity financing transactions. Mr. Levinson has represented issuers, investment bankers and independent directors in numerous proxy contests, tender offers, recapitalizations and going private transactions. His merger and acquisition work has included friendly and hostile acquisitions and dispositions in one-step and two-step transactions, including the preparation and filing of securities registration statements and proxy statements on both the buyer and seller side. His financing work has included bank borrowing and debt and equity issuances, as well as initial public offerings and subsequent public offerings.

Mr. Levinson has been a partner at several of New York’s most prestigious law firms,including Phillips Nizer, LLP, Shereff, Friedman, Hoffman & Goodman, LLP (now known as Dechert, LLP), and Herzfeld & Rubin, P.C. He previously served as Senior Attorney in the Securities and Corporate Practices section of the Chief Counsel’s Office of the United States Office of the Comptroller of the Currency.

Mr. Levinson received his B.A. degree from Yale University and his J.D. degree, with high honors, from the University of Connecticut. He also holds an M.B.A. degree from Columbia University, where he was elected to the Beta Gamma Sigma honor society. He is admitted to practice in New York, Connecticut and the District of Columbia.

Experience and Success

• Served as Senior Attorney in the office of Chief Counsel to the U.S. Comptroller of the Currency dealing with regulatory and securities matters, in which capacity he wrote and successfully defended several key opinions on the securities activities of national banks.
• Participated in the reverse mergers of CytoSorbent Technologies, Inc., ChromaDex Corporation, Intellect Neurosciences, Inc., Novelos Therapeutices, Inc., Stem Cell Innovations, Inc. and numerous other companies in the biotechnology and information technology industries, as counsel to the issuers or to key investors, including preparing Federal Securities Act and Securities and Exchange Act filings, making filings with securities exchanges and FINRA and working on related and follow-on financing transactions, having an aggregate value of more than $2 billion.
• Acted as counsel to the surviving entity in leverage buyouts/roll-ups of Nations Flooring, Inc., American Rockwool, Inc. and Millennium Services, Inc., among many others, and handled the subsequent acquisition and financing activity and public offerings.
• Acted as counsel to issuers, underwriters or selling shareholders in numerous public offerings, including Aegis Financial Services, Inc., Vitacost.com, Inc., Peoples Savings Bank.